middle.news
Invex Therapeutics Unveils Promising Alzheimer's Data from Exenatide Collaboration
9:02am on Wednesday 22nd of January, 2025 AEDT
•
Biopharmaceutical
Read Story
Invex Therapeutics Unveils Promising Alzheimer's Data from Exenatide Collaboration
9:02am on Wednesday 22nd of January, 2025 AEDT
Key Points
Exenatide increases neuronal cell viability by up to 45% in Alzheimer's disease model
First evidence of GLP-1 receptor agonist efficacy in 3D human brain Alzheimer's model
Stable cash reserves of $5.8 million with controlled operating outflows
Ongoing discussions with potential partners to expand neurological pipeline
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invex Therapeutics (ASX:IXC)
OPEN ARTICLE